Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PHAR Pharming Group > Key Indicators
PHAR Pharming Group
10.860
+0.226+2.13%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
34.04% -227.101 64.55% 274.8119 64.55% 274.8119 18.9% -248.9593
Receivable Turnover(T)
-3.35% 6.278 -0.53% 9.5546 -0.53% 9.5546 -5.53% 6.6294
Inventory Turnover(T)
-35.39% 0.825 -35.66% 0.8718 -35.66% 0.8718 -28.24% 1.0418
Fixed Assets Turnover(T)
-34.69% 7.5096 -39.73% 7.2513 -39.73% 7.2513 -38.21% 7.3907
Total Asset Rate(T)
-13.34% 0.504 -28.04% 0.4872 -28.04% 0.4872 -20.86% 0.5456
ROIC
-48.08% 5.504% -66.96% 5.761% -66.96% 5.761% -91.93% 2.030%
ROE
-77.22% 5.754% -68.54% 8.494% -68.54% 8.494% -60.18% 13.616%
ROA
-74.38% 2.729% -67.46% 3.919% -67.46% 3.919% -56.81% 6.204%
FCF to Sales
-70.96% 8.549% -67.44% 10.623% -67.44% 10.623% -54.4% 15.323%
FCF to Net Income
-1.82% 157.875% -27.98% 132.071% -27.98% 132.071% -16.46% 134.766%
Efficiency Ratios
ROE 5 Year Average
-- -- 24.51% -46.585% -- -- -- --
ROA 5 Year Average
-- -- 64.19% -2.532% -- -- -- --
Average 5 Years ROIC
-- -- 204.39% 2.683% -- -- -- --
Profitability Ratios TTM
Gross Margin
0.73% 89.513% 0.52% 89.369% 0.52% 89.369% 0.09% 89.091%
Operating Margin
-75.04% 7.701% -73.41% 9.558% -73.41% 9.558% -54.6% 17.426%
Net Margin
-70.43% 5.415% -54.79% 8.043% -54.79% 8.043% -45.42% 11.370%
EBITDA Margin
-21.69% 0.1987% -10.81% 0.2453% -10.81% 0.2453% -67.64% 0.1292%
R & D Expense Ratio
85.66% 36.910% 94.93% 35.380% 94.93% 35.380% 86.03% 29.560%
Sales Expense Ratio
15.68% 30.610% 22.9% 29.890% 22.9% 29.890% 22.63% 28.500%
Administration Expense Rate
56.08% 11.300% 77.34% 11.190% 77.34% 11.190% -20.47% 9.520%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-1.01% 79.097% -5.21% 81.623% -5.21% 81.623% -12.05% 82.814%
Total Assets to Common Equity
-7.82% 202.451% -9.72% 205.952% -9.72% 205.952% -11.62% 207.153%
Debt to Asset Ratio
-1.51% 81.325% -5.03% 83.851% -5.03% 83.851% -10.78% 85.148%
Current Ratio
56.46% 5.558 55.71% 5.3333 55.71% 5.3333 -4.24% 5.1842
Quick Ratio
50.94% 4.8973 52.15% 4.6934 52.15% 4.6934 -6.83% 4.626
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -69.31% 8.762% -- -- -- --
Revenue CAGR(5Y)
-- -- -20.58% 64.136% -- -- -- --
Net Income CAGR(3Y)
-- -- -- -17.599% -- -- -- --
FCF 1 Year Growth
-- -- -238.55% -71.646% -- -- -- --
FCF CAGR(3Y)
-- -- -183.17% -20.392% -- -- -- --
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CEO: --
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top